These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12170258)

  • 21. The Use of pMHCII Tetramer Technology for the Identification and Characterization of CD4+ T Cells.
    Wambre E
    Methods Mol Biol; 2019; 2020():153-164. PubMed ID: 31177498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
    McMenamin C; Holt PG
    J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliable generation and use of MHC class II:gamma2aFc multimers for the identification of antigen-specific CD4(+) T cells.
    Arnold PY; Vignali KM; Miller TB; La Gruta NL; Cauley LS; Haynes L; Scott Adams P; Swain SL; Woodland DL; Vignali DA
    J Immunol Methods; 2002 Dec; 271(1-2):137-51. PubMed ID: 12445737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of class II tetramers for identification of CD4+ T cells.
    Kwok WW; Ptacek NA; Liu AW; Buckner JH
    J Immunol Methods; 2002 Oct; 268(1):71-81. PubMed ID: 12213344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of mammaglobin-A-specific CD4 T cells and identification of candidate CD4 epitopes for breast cancer vaccine strategies.
    Viehl CT; Frey DM; Phommaly C; Chen T; Fleming TP; Gillanders WE; Eberlein TJ; Goedegebuure PS
    Breast Cancer Res Treat; 2008 May; 109(2):305-14. PubMed ID: 17653857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of MHC class II-restricted T-cell epitopes in prostate-specific membrane antigen.
    Schroers R; Shen L; Rollins L; Xiao Z; Sonderstrup G; Slawin K; Huang XF; Chen SY
    Clin Cancer Res; 2003 Aug; 9(9):3260-71. PubMed ID: 12960111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major Histocompatibility Complex Class II Dextramers: New Tools for the Detection of antigen-Specific, CD4 T Cells in Basic and Clinical Research.
    Massilamany C; Krishnan B; Reddy J
    Scand J Immunol; 2015 Nov; 82(5):399-408. PubMed ID: 26207337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Human Antigen-Specific CD4
    Kong YY; Kwok WW
    Methods Mol Biol; 2019; 1988():375-386. PubMed ID: 31147953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of human antigen-specific T cells using MHC class I and class II tetramers.
    Krueger LA; Nugent CT; Hampl J
    Curr Protoc Cytom; 2004 Nov; Chapter 6():Unit 6.18. PubMed ID: 18770797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of low-avidity CD4+ T cells using recombinant artificial APC: following the antiovalbumin immune response.
    Mallet-Designe VI; Stratmann T; Homann D; Carbone F; Oldstone MB; Teyton L
    J Immunol; 2003 Jan; 170(1):123-31. PubMed ID: 12496391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.
    Murphy B; Magee CC; Alexander SI; Waaga AM; Snoeck HW; Vella JP; Carpenter CB; Sayegh MH
    J Clin Invest; 1999 Mar; 103(6):859-67. PubMed ID: 10079107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.
    Oling V; Marttila J; Ilonen J; Kwok WW; Nepom G; Knip M; Simell O; Reijonen H
    J Autoimmun; 2005 Nov; 25(3):235-43. PubMed ID: 16263242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of autoreactive myelin proteolipid protein 139-151-specific T cells by using MHC II (IAs) tetramers.
    Reddy J; Bettelli E; Nicholson L; Waldner H; Jang MH; Wucherpfennig KW; Kuchroo VK
    J Immunol; 2003 Jan; 170(2):870-7. PubMed ID: 12517952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutant MHC class II epitopes drive therapeutic immune responses to cancer.
    Kreiter S; Vormehr M; van de Roemer N; Diken M; Löwer M; Diekmann J; Boegel S; Schrörs B; Vascotto F; Castle JC; Tadmor AD; Schoenberger SP; Huber C; Türeci Ö; Sahin U
    Nature; 2015 Apr; 520(7549):692-6. PubMed ID: 25901682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells.
    Tsuji T; Matsuzaki J; Caballero OL; Jungbluth AA; Ritter G; Odunsi K; Old LJ; Gnjatic S
    J Immunol; 2012 Apr; 188(8):3851-8. PubMed ID: 22427632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The alloreactive and self-restricted CD4+ T cell response directed against a single MHC class II/peptide combination.
    Kovalik JP; Singh N; Mendiratta SK; Martin WD; Ignatowicz L; Van Kaer L
    J Immunol; 2000 Aug; 165(3):1285-93. PubMed ID: 10903728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen-specific CD4+ T cells recognize epitopes of protective antigen following vaccination with an anthrax vaccine.
    Laughlin EM; Miller JD; James E; Fillos D; Ibegbu CC; Mittler RS; Akondy R; Kwok W; Ahmed R; Nepom G
    Infect Immun; 2007 Apr; 75(4):1852-60. PubMed ID: 17283103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
    Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N
    Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.
    Aarntzen EH; De Vries IJ; Lesterhuis WJ; Schuurhuis D; Jacobs JF; Bol K; Schreibelt G; Mus R; De Wilt JH; Haanen JB; Schadendorf D; Croockewit A; Blokx WA; Van Rossum MM; Kwok WW; Adema GJ; Punt CJ; Figdor CG
    Cancer Res; 2013 Jan; 73(1):19-29. PubMed ID: 23087058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.